QuidelOrtho (QDEL:NASDAQ) Investor Relations Material

Overview

California-based QuidelOrtho Corporation has established itself as a leader in the development and manufacture of diagnostic testing technologies and solutions. With business units divided into Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics, the company offers a range of clinical chemistry and immunoassay laboratory instruments and specialized diagnostic solutions. It also provides immunohematology instruments and tests for blood typing and donor screening, as well as rapid-result instruments and tests for syndromic infectious disease diagnostics. The company utilizes both a direct sales force and a network of distributors to sell its products to end-users in North America, Europe, the Middle East, Africa, China, and beyond. Founded in 1979, QuidelOrtho Corporation continues to be at the forefront of medical technology innovation.

Frequently Asked Questions

What is QuidelOrtho's ticker?

QuidelOrtho's ticker is QDEL

What exchange is QuidelOrtho traded on?

The company's shares trade on the NASDAQ stock exchange

Where are QuidelOrtho's headquarters?

They are based in San Diego, California

How many employees does QuidelOrtho have?

There are 501-1000 employees working at QuidelOrtho

What is QuidelOrtho's website?

It is quidel.com

What type of sector is QuidelOrtho?

QuidelOrtho is in the Healthcare sector

What type of industry is QuidelOrtho?

QuidelOrtho is in the Diagnostic Substances industry

Who are QuidelOrtho's peers and competitors?

The following five companies are QuidelOrtho's industry peers:

- DermTech

- Surmodics

- Co-Diagnostics Inc

- CareDx

- Oxford Immunotec Global PLC